UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 25, 2018

 

Nexeon Medsystems Inc

(Exact name of registrant as specified in its charter)

 

Nevada   000-55655   81-0756622
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1910 Pacific Avenue, Suite 20000

Dallas, Texas 75201

(Address of principal executive offices) (zip code)

 

844-919-9990

(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report.)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

On June 25, 2018, Nexeon Medsystems Inc. (the “Company”) filed a certificate of amendment (the “Amendment”) to its Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share. A copy of the Amendment is attached to this Current Report as Exhibit 3.1.

 

As previously disclosed on a Current Report on Form 8-K filed on May 17, 2018, on May 14, 2018, the stockholders of the Company approved the Amendment to effect a reverse split of Registrant’s issued and outstanding common stock at a ratio of not less than 1 for 2 and not more than 1 for 25, at any time prior to May 14, 2019, at the discretion of the Company’s Board of Directors.

 

On June 13, 2018, the Company’s Board of Directors authorized a reverse stock split at a ratio of 1 for 14, which took effect on June 28, 2018. As a result of the reverse stock split, every fourteen shares of the Company’s pre-reverse split common stock will be combined and reclassified into one share of the Company’s common stock. No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders who otherwise would be entitled to a fractional share shall receive the next higher number of whole shares.

 

The par value and other terms of Company’s common stock were not affected by the reverse stock split. The new CUSIP number of the Company’s post-reverse split common stock is 65342G203. The symbol of the Company’s common stock will trade with a “D” added, under the symbol “NXNND”, for the 20 business days beginning June 28, 2018 to designate that it is trading on a post-reverse split basis. Trading will resume under the symbol “NXNN” after the 20 day period has expired. The Company’s transfer agent, Equity Stock Transfer LLC, is acting as exchange agent for the reverse stock split and will send instructions to stockholders of record regarding the exchange of certificates for common stock, if any.

  

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

The following exhibits are filed herewith:

 

  Exhibit 3.1 Certificate of Amendment to Articles of Incorporation dated June 25, 2018
     

 

 1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEXEON MEDSYSTEMS INC
   
Dated: June 28, 2018 /s/ William Rosellini
  William Rosellini 
  Chairman and Chief Executive Officer

 

 

2

 

 

Exhibit 3.1

 

STATE OF NEVADA

 

BARBARA K. CEGAVSKE

Secretary of State

KIMBERLEY PERONDI

Deputy Secretary
for Commercial Recordings

 

OFFICE OF THE

SECRETARY OF STATE

 

Certified Copy

 

June 25, 2018

 

Job Number: C20180625-2373
Reference Number:  
Expedite:  
Through Date:  

 

The undersigned filing officer hereby certifies that the attached copies are true and exact copies of all requested statements and related subsequent documentation filed with the Secretary of State’s Office, Commercial Recordings Division listed on the attached report.

 

Document Number(s) Description Number of Pages
20180284192-07 Amendment 3 Pages/1 Copies

 

 

 

Certified By: Nita Hibshman

Certificate Number: C20180625-2373

 

Respectfully,

 

/s/ Barbara K. Cegavske

 

Barbara K. Cegavske

Secretary of State

 

Commercial Recording Division

202 N. Carson Street

Carson City, Nevada 89701-4201

Telephone (775) 684-5708

Fax (775) 684-7138

 

 

 

 

 

BARBARA K. CEGAVSKE

Secretary of State

202 North Carson Street

Carson City, Nevada 89701-4201

(775) 684-5708

Website: www.nvsos.gov

 

 

 

Filed in the office of

/s/ Barbara K. Cegavske

 

Document Number

20180284192-07

 

Barbara K. Cegavske

Secretary of State

 

Filing Date and Time

06/25/2018 2:38 PM

  State of Nevada  

Entity Number

E0567502015-5

 

 

Certificate of Amendment

(PURSUANT TO NRS 78.385 AND 78.390)

 

 

 

USE BLACK INK ONLY - DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY

 

Certificate of Amendment to Articles of Incorporation

For Nevada Profit Corporations

(Pursuant to NRS 78.385 and 78.390 - After Issuance of stock)

 

1. Name of corporation:

 

NEXEON MEDSYSTEMS INC.

 

2. The articles have been amended as follows: (provide article numbers, if available)

 

Article IX is hereby amended by adding the following:

 

“Upon the filing of this Amendment with the Secretary of State of the State of Nevada (the “Effective Time”), each fourteen (14) outstanding shares of Common Stock (the “Old Common Stock”) shall be split and converted into one (l) share of Common Stock (the “New Common Stock”). This reverse stock split (the “Reverse Split”) of the outstanding shares of Common Stock shall not affect the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, which shall remain as set forth in this Article IX.

 

3. The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is: ____________________________

 

4. Effective date and time of filing: (optional) Date:  ___________________            Time:  _______________
  (must not be later than 90 days after the certificate is filed)

 

5. Signature: (required)

 

X  

Signature of Officer

 

*If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof.

 

IMPORTANT: Failure to include any of the above information and submit with the proper fees may cause this filing to be rejected.

 

This form must be accompanied by appropriate fees.

Nevada Secretary of State Amend Profit-After

Revised:1-5-15

 

 

 

 

CERTIFICATE OF AMENDMENT

 

TO

 

THE ARTICLES OF INCORPORATION, AS AMENDED,

 

OF

 

NEXEON MEDSYSTEMS INC.

 

Nexeon Medsystems Inc., a corporation organized and existing under the laws of the State of Nevada (the “Corporation”) hereby certifies that the amendment set forth below to the Corporation’s Articles of Incorporation (the “Articles”) was duly adopted in accordance with Sections 78.385 and 78.390 of the Nevada Revised Statutes:

 

The Articles have been amended as follows:

 

1.    Article IX is hereby amended by adding the following:

 

“Upon the filing of this Amendment with the Secretary of State of the State of Nevada (the “Effective Time”), each fourteen (14) outstanding shares of Common Stock (the “Old Common Stock”) shall be split and converted into one (1) share of Common Stock (the “New Common Stock”). This reverse stock split (the “Reverse Split”) of the outstanding shares of Common Stock shall not affect the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, which shall remain as set forth in this Article IX.

 

The Reverse Split shall occur without any further action on the part of the Corporation or the holders of shares of New Common Stock and whether or not certificates representing such holders’ shares prior to the Reverse Split are surrendered for cancellation. No fractional interest in a share of New Common Stock shall be deliverable upon the Reverse Split, all of which shares of New Common Stock shall be rounded up to the nearest whole number of such shares. All references to “Common Stock” in these Articles shall be to the New Common Stock.

 

The Reverse Split will be effectuated on a stockholder-by-stockholder (as opposed to certificate-by-certificate) basis. Certificates dated as of a date prior to the Effective Time representing outstanding shares of Old Common Stock shall, after the Effective Time, represent a number of shares equal to the same number of shares of New Common Stock as is reflected on the face of such certificates, divided by fourteen (14) and rounded up to the nearest whole number. The Corporation shall not be obligated to issue new certificates evidencing the shares of New Common Stock outstanding as a result of the Reverse Split unless and until the certificates evidencing the shares held by a holder prior to the Reverse Split are either delivered to the Corporation or its transfer agent, or the holder notifies the Corporation or its transfer agent that such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates.”

 

2.    The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation have voted in favor of the amendment is: greater than 50%

 

3.    Effective date of filing: June 25, 2018

 

 

 

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its duly authorized officer as of June 25, 2018.

 

  By: /s/ William Rosellini
  Name: William Rosellini
  Title: Chief Executive Officer